Piramal Pharma (PPLPHARMA) Share Price Falls 2.26% to Rs 209.80

Published:   22 September 2026 at 3:32:53 PM IST

Piramal Pharma Share Price moved lower on 22 September 2026, with the stock at Rs 209.80 after a 2.26% decline. The company’s market capitalisation stood at Rs 27,692.04 crore, placing Piramal Pharma in the Large Cap category. The day’s move is visible in the live price, but the supplied data does not establish a company-specific catalyst for the fall. For investors following Piramal Pharma Share Price Today, the key task is to read the decline alongside valuation, profitability, sector benchmarks and peer positioning rather than treat it as a standalone event. Univest data points to a mixed fundamental backdrop, and Piramal Pharma Stock News is relevant because the stock is moving within a broader pharmaceuticals and drugs context in the Healthcare sector.

Piramal Pharma (PPLPHARMA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 209.8
Previous Close	Rs 214.65
Today's Move	-Rs 4.85 (-2.26%)
Open	Rs 215.75
High	Rs 215.85
Low	Rs 209.6
Turnover	Rs 3.05 crore
Market Capitalisation	Rs 27,692.04 crore
Market Cap Category	Large Cap

Piramal Pharma Share Price Today opened at Rs 215.75, moved to a high of Rs 215.85 and a low of Rs 209.6, before ending at Rs 209.80. Against the previous close of Rs 214.65, the stock declined by Rs 4.85 or 2.26%. That makes the day’s move easy to quantify: the share price fell below the prior close and finished near the session low. Turnover stood at Rs 3.05 crore, which is the exact traded value for the day and should be read as a factual market metric rather than an explanation for the move. The event matters because Piramal Pharma Share Price is being tracked as a same-day decline in a Large Cap stock, and that keeps Piramal Pharma Stock News in focus for market watchers. From here, the next layer of analysis is the company’s financial profile and the sector backdrop that helps frame Piramal Pharma Share Price movement.

Piramal Pharma (PPLPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 27,692.04 crore
P/B Ratio	3.57x
ROE	-4.04%
ROCE	1.24%
EPS	Rs -2.36
Book Value Per Share	Rs 60.13
Dividend Yield	0%

Piramal Pharma fundamental analysis shows a market capitalisation of Rs 27,692.04 crore and a price-to-book ratio of 3.57. The book value per share is Rs 60.13, while earnings per share stand at Rs -2.36, indicating a loss on the latest supplied earnings metric. Return on equity is -4.04%, and return on capital employed is 1.24%, which adds important context to Piramal Pharma Share Price because profitability metrics are not yet strong on the supplied numbers. Dividend yield is 0, so there is no dividend yield contribution in the current data set. In simple terms, the company is priced above its book value, but the negative EPS and negative ROE mean the valuation needs to be read carefully. For Piramal Pharma Share Price Today, these figures matter because stock news around the decline is best assessed against earnings quality, capital efficiency and balance-sheet-linked value measures. Univest readers can therefore view Piramal Pharma Stock News through a fundamental lens rather than a price-only lens.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Benchmark Median P/E	32.62x
Benchmark Average P/E	49.51x
Benchmark P/E Range	3.37x to 747.32x
Company P/B Ratio	3.57x
Benchmark Median P/B	3x
Benchmark Average P/B	4.35x
Company ROE	-4.04%
Benchmark Median ROE	11.74%
Benchmark Average ROE	10.79%
Company ROCE	1.24%
Benchmark Median ROCE	13.63%
Benchmark Average ROCE	13.4%
Company Market Capitalisation	Rs 27,692.04 crore
Benchmark Median Market Cap	Rs 746.45 crore
Benchmark Average Market Cap	Rs 14,202.67 crore

Piramal Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The sector snapshot covers the same industry with 200 companies, which is a broad benchmark set for comparison.The company’s P/B of 3.57 is above the industry median P/B of 3.00 and below the industry average P/B of 4.35 across 199 companies. Its ROE of -4.04% is below the industry median ROE of 11.74% and the industry average ROE of 10.79% across 200 companies. ROCE at 1.24% is also below the industry median ROCE of 13.63% and the industry average ROCE of 13.40% across 200 companies. On market size, Piramal Pharma’s Rs 27,692.04 crore market cap is above the industry median of Rs 746.45 crore and above the industry average of Rs 14,202.67 crore across 200 companies. This sector context is important for Piramal Pharma Share Price because it places the stock within a large, established industry benchmark while also showing weaker profitability metrics than the broader industry sample.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,40,397.93	37.05	5.18	14.85	19.11
Divi's Laboratories	DIVISLAB	2,48,664.42	85.6	14.18	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,82,738.23	86.64	21.05	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,15,012.19	25.67	4.3	19.69	21.39
Cipla	CIPLA	1,10,793.75	33.19	3.18	11.83	16

Peer comparison helps position Piramal Pharma Share Price against other listed names in Pharmaceuticals & Drugs. Compared with Sun Pharmaceutical Industries at Rs 4,40,397.93 crore market cap, P/E 37.05, P/B 5.18, ROE 14.85% and ROCE 19.11%, Piramal Pharma is much smaller and trades on a lower P/B. Divi’s Laboratories shows a market cap of Rs 2,48,664.42 crore, P/E 85.6, P/B 14.18, ROE 16.19% and ROCE 21.51%, again above Piramal Pharma on most displayed metrics. Torrent Pharmaceuticals carries Rs 1,82,738.23 crore market cap, P/E 86.64, P/B 21.05, ROE 26.76% and ROCE 19.27%. Zydus Lifesciences has Rs 1,15,012.19 crore market cap, P/E 25.67, P/B 4.3, ROE 19.69% and ROCE 21.39%. On the peer set shown, Piramal Pharma Share Price sits alongside companies with materially different valuation and profitability profiles, which is why Piramal Pharma Stock Analysis remains relevant even on a one-day decline.

Why Investors Are Watching Piramal Pharma

• Piramal Pharma Share Price fell 2.26% today to Rs 209.80.
• The stock closed below the previous close of Rs 214.65 after opening at Rs 215.75.
• Turnover stood at Rs 3.05 crore in the latest session.
• Market capitalisation is Rs 27,692.04 crore, with Large Cap classification.
• P/B is 3.57, EPS is Rs -2.36, ROE is -4.04% and ROCE is 1.24%.

About Piramal Pharma

Piramal Pharma is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company within a broad industry benchmark set of 200 companies. In this article, Univest uses only the verified market-capitalisation, valuation and profitability figures to frame Piramal Pharma Share Price Today. That approach keeps the discussion grounded in the current dataset and avoids adding unsupported company detail. For readers tracking Piramal Pharma Stock News, the most useful takeaway is that today’s price fall should be read together with the company’s negative EPS, negative ROE and modest ROCE relative to the industry snapshot.

Track Piramal Pharma Share Price on Univest

Use Piramal Pharma (PPLPHARMA) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

You can track Piramal Pharma Share Price on Univest for live price updates, financial ratios, shareholding pattern when available, 52-week levels, company news and market insights. Univest brings the company page, stock analysis and peer context into one place for quick review. That makes it easier to follow Piramal Pharma Share Price Today alongside fundamentals, sector comparisons and stock performance on a single screen.

Frequently Asked Questions

Why did Piramal Pharma Share Price fall today?

Ans.  The supplied data confirms that Piramal Pharma Share Price fell 2.26% to Rs 209.80, but it does not establish a company-specific catalyst. The note therefore focuses on verified price action, fundamentals and sector context.

What is Piramal Pharma Share Price today?

Ans.  Piramal Pharma Share Price today is Rs 209.80. The stock declined Rs 4.85 from the previous close of Rs 214.65 after opening at Rs 215.75 and moving between Rs 215.85 and Rs 209.6.

What is Piramal Pharma’s market capitalisation?

Ans.  Piramal Pharma’s market capitalisation is Rs 27,692.04 crore. The stock is classified as Large Cap in the supplied data, which gives useful size context for Piramal Pharma Share Price and its daily move.

What do Piramal Pharma’s valuation and profitability metrics show?

Ans.  Piramal Pharma has a P/B of 3.57, EPS of Rs -2.36, ROE of -4.04% and ROCE of 1.24%. Those figures show that Piramal Pharma Share Price is being assessed against weak profitability metrics.

How does Piramal Pharma compare with its healthcare peers?

Ans.  Compared with peers such as Sun Pharma, Divi’s Laboratories, Torrent Pharma and Zydus Lifesciences, Piramal Pharma has a much smaller market cap and lower profitability metrics. That peer gap helps frame Piramal Pharma Share Price Today.

What should investors monitor next in Piramal Pharma Share Price?

Ans.  Investors can monitor whether Piramal Pharma Share Price holds around Rs 209.80, how turnover behaves in later sessions, and whether fundamentals such as EPS, ROE and ROCE improve in future reporting periods.